Qualyst, Inc. and SOLVO Biotechnology Announce Alliance  
12/5/2007 7:57:44 AM

Solvo Biotechnology, a leading provider of drug transport technologies, cell products and contract in vitro and in vivo laboratory services, and Qualyst, Inc., a leader in the development and commercialization of novel and proprietary absorption, distribution, metabolism, excretion and toxicity (ADMET) technologies, today announced that Solvo has obtained a license to Qualyst’s B CLEAR® system. B-CLEAR® products and services are projected to be available in Europe from Solvo in early 2008. Financial details were not disclosed.